FI954138L - Hydroximetylfurazankarboxylsyraderivat och deras användning vid behandling av kardiovaskulära sjukdomar - Google Patents
Hydroximetylfurazankarboxylsyraderivat och deras användning vid behandling av kardiovaskulära sjukdomar Download PDFInfo
- Publication number
- FI954138L FI954138L FI954138A FI954138A FI954138L FI 954138 L FI954138 L FI 954138L FI 954138 A FI954138 A FI 954138A FI 954138 A FI954138 A FI 954138A FI 954138 L FI954138 L FI 954138L
- Authority
- FI
- Finland
- Prior art keywords
- treatment
- acid derivatives
- cardiovascular diseases
- hydroxymethylfurazancarboxylic
- hydroxymethylfurazancarboxylic acid
- Prior art date
Links
- KARWJKFMHIOFPB-UHFFFAOYSA-N 4-(hydroxymethyl)-1,2,5-oxadiazole-3-carboxylic acid Chemical class OCC1=NON=C1C(O)=O KARWJKFMHIOFPB-UHFFFAOYSA-N 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4307105A DE4307105A1 (de) | 1993-03-06 | 1993-03-06 | Hydroxymethylfurazancarbonsäurederivate |
| PCT/EP1994/000459 WO1994020478A1 (de) | 1993-03-06 | 1994-02-18 | Hydroxymethylfurazancarbonsäurederivate und ihre verwendung in der behandlung von kardiovaskulären erkrankungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI954138A0 FI954138A0 (sv) | 1995-09-04 |
| FI954138L true FI954138L (sv) | 1995-09-04 |
Family
ID=6482135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI954138A FI954138L (sv) | 1993-03-06 | 1995-09-04 | Hydroximetylfurazankarboxylsyraderivat och deras användning vid behandling av kardiovaskulära sjukdomar |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5486531A (sv) |
| EP (1) | EP0687256B1 (sv) |
| JP (1) | JP3578456B2 (sv) |
| KR (1) | KR960701029A (sv) |
| CN (1) | CN1043140C (sv) |
| AT (1) | ATE157660T1 (sv) |
| AU (1) | AU676718B2 (sv) |
| CA (1) | CA2155840C (sv) |
| CZ (1) | CZ284264B6 (sv) |
| DE (2) | DE4307105A1 (sv) |
| DK (1) | DK0687256T3 (sv) |
| ES (1) | ES2108977T3 (sv) |
| FI (1) | FI954138L (sv) |
| GR (1) | GR3024928T3 (sv) |
| HU (1) | HUT72641A (sv) |
| IL (1) | IL108856A (sv) |
| PL (1) | PL177603B1 (sv) |
| RU (1) | RU2134687C1 (sv) |
| SK (1) | SK280354B6 (sv) |
| WO (1) | WO1994020478A1 (sv) |
| ZA (1) | ZA941533B (sv) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4401150A1 (de) * | 1994-01-17 | 1995-07-20 | Cassella Ag | Furazancarbonsäurederivate |
| US6191131B1 (en) | 1997-07-23 | 2001-02-20 | Dupont Pharmaceuticals Company | Azolo triazines and pyrimidines |
| US6124289A (en) * | 1996-07-24 | 2000-09-26 | Dupont Pharmaceuticals Co. | Azolo triazines and pyrimidines |
| US6313124B1 (en) | 1997-07-23 | 2001-11-06 | Dupont Pharmaceuticals Company | Tetrazine bicyclic compounds |
| US7094782B1 (en) | 1996-07-24 | 2006-08-22 | Bristol-Myers Squibb Company | Azolo triazines and pyrimidines |
| US6060478A (en) * | 1996-07-24 | 2000-05-09 | Dupont Pharmaceuticals | Azolo triazines and pyrimidines |
| CN100434428C (zh) * | 2003-05-23 | 2008-11-19 | 巴斯利尔药物股份公司 | 呋咱并苯并咪唑类化合物 |
| US8822509B2 (en) | 2006-12-29 | 2014-09-02 | The University Of Queensland | Pain-relieving compositions and uses therefor |
| CN112125865B (zh) * | 2020-09-30 | 2022-08-12 | 北京理工大学 | 氧化呋咱化合物的合成方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3012862A1 (de) * | 1980-04-02 | 1981-10-08 | Cassella Ag, 6000 Frankfurt | Substituierte 1,2,5-oxdiazol-2-oxide als pharmazeutische wirkstoffe, ihre verwendung und sie enthaltende arzneimittel |
| DE3047730A1 (de) * | 1980-12-18 | 1982-07-15 | Cassella Ag, 6000 Frankfurt | 3,4-bis-substituierte 1,2,5-oxdiazol-2-oxide, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen |
-
1993
- 1993-03-06 DE DE4307105A patent/DE4307105A1/de not_active Withdrawn
-
1994
- 1994-02-18 CZ CZ952281A patent/CZ284264B6/cs not_active IP Right Cessation
- 1994-02-18 PL PL94310655A patent/PL177603B1/pl unknown
- 1994-02-18 JP JP51951094A patent/JP3578456B2/ja not_active Expired - Fee Related
- 1994-02-18 WO PCT/EP1994/000459 patent/WO1994020478A1/de active IP Right Grant
- 1994-02-18 EP EP94908337A patent/EP0687256B1/de not_active Expired - Lifetime
- 1994-02-18 AT AT94908337T patent/ATE157660T1/de not_active IP Right Cessation
- 1994-02-18 CA CA002155840A patent/CA2155840C/en not_active Expired - Fee Related
- 1994-02-18 DE DE59403966T patent/DE59403966D1/de not_active Expired - Lifetime
- 1994-02-18 DK DK94908337.2T patent/DK0687256T3/da active
- 1994-02-18 RU RU95118170A patent/RU2134687C1/ru active
- 1994-02-18 CN CN94191395A patent/CN1043140C/zh not_active Expired - Fee Related
- 1994-02-18 KR KR1019950703761A patent/KR960701029A/ko not_active Ceased
- 1994-02-18 AU AU61414/94A patent/AU676718B2/en not_active Ceased
- 1994-02-18 SK SK1110-95A patent/SK280354B6/sk unknown
- 1994-02-18 ES ES94908337T patent/ES2108977T3/es not_active Expired - Lifetime
- 1994-02-18 HU HU9502603A patent/HUT72641A/hu unknown
- 1994-03-04 ZA ZA941533A patent/ZA941533B/xx unknown
- 1994-03-04 IL IL108856A patent/IL108856A/xx active IP Right Grant
- 1994-03-07 US US08/207,280 patent/US5486531A/en not_active Expired - Lifetime
-
1995
- 1995-09-04 FI FI954138A patent/FI954138L/sv unknown
-
1997
- 1997-10-03 GR GR970402569T patent/GR3024928T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE157660T1 (de) | 1997-09-15 |
| GR3024928T3 (en) | 1998-01-30 |
| KR960701029A (ko) | 1996-02-24 |
| EP0687256B1 (de) | 1997-09-03 |
| CZ284264B6 (cs) | 1998-10-14 |
| HUT72641A (en) | 1996-05-28 |
| JP3578456B2 (ja) | 2004-10-20 |
| CA2155840A1 (en) | 1994-09-15 |
| AU6141494A (en) | 1994-09-26 |
| DE4307105A1 (de) | 1994-09-08 |
| SK110095A3 (en) | 1996-01-10 |
| DK0687256T3 (da) | 1998-03-30 |
| SK280354B6 (sk) | 1999-12-10 |
| IL108856A (en) | 1997-07-13 |
| DE59403966D1 (de) | 1997-10-09 |
| JPH08507299A (ja) | 1996-08-06 |
| CA2155840C (en) | 2005-05-24 |
| EP0687256A1 (de) | 1995-12-20 |
| CN1119013A (zh) | 1996-03-20 |
| FI954138A0 (sv) | 1995-09-04 |
| PL177603B1 (pl) | 1999-12-31 |
| IL108856A0 (en) | 1994-06-24 |
| WO1994020478A1 (de) | 1994-09-15 |
| CN1043140C (zh) | 1999-04-28 |
| HU9502603D0 (en) | 1995-11-28 |
| RU2134687C1 (ru) | 1999-08-20 |
| AU676718B2 (en) | 1997-03-20 |
| US5486531A (en) | 1996-01-23 |
| ES2108977T3 (es) | 1998-01-01 |
| CZ228195A3 (en) | 1995-12-13 |
| ZA941533B (en) | 1994-10-06 |
| PL310655A1 (en) | 1995-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI953838L (sv) | Imidazopyridiner och användning av dem vid behandling av gastrointestinala sjukdomar | |
| FI944549A0 (sv) | Föreningar nyttiga för behandling av allergiska och inflammatoriska sjukdomer | |
| EE9700039A (et) | Teraapias kasutatavad spiro-asabitsüklilised ühendid ja nende valmistamise protsess | |
| NO180232C (no) | Karboksylsyrederivater, legemidler inneholdende disse, og anvendelse av disse for fremstilling av legemidler | |
| BR9406209A (pt) | Derivados heterociclicos no tratamento de isquemia e doenças relacionadas | |
| FI970214L (sv) | Användning av droloxifen vid behandling av kardiovaskulära sjukdomar | |
| FI953479A0 (sv) | 1-arylpyrimidinderivat och farmaceutisk användning av dessa | |
| FI944600L (sv) | Imidazol-4-ylpiperidinderivat, framställning av dessa och användning av dessa inom terapin | |
| FI951060L (sv) | Formulationer och behandlingsmetoder | |
| FI964901L (sv) | Förfarande för framställning av alfa-metoxiiminokarboxylsyrametylamider och mellanprodukter som använts i förfarandet | |
| FI960585L (sv) | Användning av oligosackarider för hindrande och behandling av vävnadsåldrande | |
| FI964482L (sv) | Amidderivat och deras användning som läkemedel | |
| FI955786A (sv) | Användning av naturprodukter och liknande syntetiska föreningar vid behandling av kardiovakulära sjukdomar | |
| FI954138L (sv) | Hydroximetylfurazankarboxylsyraderivat och deras användning vid behandling av kardiovaskulära sjukdomar | |
| FI971364L (sv) | Kolkicinderivat och deras terapeutiska användning | |
| FI941345A0 (sv) | Retinoider och användning av dem vid behandling av hudsjukdomar och leukemi | |
| AU4787593A (en) | Heterocyclic derivatives useful in the treatment of cardiovascular diseases | |
| FI971311L (sv) | Förfaranden för framställning av cyklopropankarboxylsyra och derivat därav | |
| FI956353L (sv) | Farmaceutiska kompositioner och deras användning speciellt för behandling av neurodegenerativa sjukdomar | |
| NO985974D0 (no) | Piperidineddiksyrederivater og deres anvendelse ved behandling av trombose-sykdommer | |
| EP0519763A3 (en) | Cyclohexylbutyric acid derivatives and their use in the production of optically active cyclohexylnorstatine | |
| FI935888L (sv) | 2-amino-6,7-dihydroxi-4-tiaheptansyraderivat, deras framstaellning och anvaendning | |
| FI955386L (sv) | 4-p-fluorbensoyl-1-piperidinyl-propoxi-kromen-4-on derivat, framställning av dessa samt användning av dem för skötsel av psykos och schizofreni | |
| AU2705495A (en) | Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory | |
| EP0453658A3 (en) | Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases |